Skip to content
InsideEdge
Investors / filer profile

No completed buy history yet — outcomes appear once a disclosed buy is ~6 months old.

Disclosed positions

Estimated from their latest filings — positions may have changed since

$758.6K
combined est. value

Activity

Open-market buy & sell volume

BuySell
0$1.9M$3.7M2025 · bought $0 · sold $3.7M20252026 · bought $0 · sold $1.3M2026
Total +$0.0000 bought · $5.02M sold

All filings on record

Every Form 4 transaction we track for this filer

KNSASell
2026-02-09 · Kiniksa Pharmaceuticals International, plc
$381.7K
KNSASell
2026-02-09 · Kiniksa Pharmaceuticals International, plc
$390.5K
KNSAExercise
2026-02-09 · Kiniksa Pharmaceuticals International, plc
$41.8K
KNSAExercise
2026-02-09 · Kiniksa Pharmaceuticals International, plc
$108.6K
KNSASell
2026-01-08 · Kiniksa Pharmaceuticals International, plc
$502.7K
KNSASell
2025-12-08 · Kiniksa Pharmaceuticals International, plc
$1.78M
KNSAExercise
2025-12-08 · Kiniksa Pharmaceuticals International, plc
$113.1K
KNSAExercise
2025-12-08 · Kiniksa Pharmaceuticals International, plc
$193.5K
KNSAExercise
2025-12-08 · Kiniksa Pharmaceuticals International, plc
$179.4K
KNSASell
2025-11-12 · Kiniksa Pharmaceuticals International, plc
$814.7K
KNSAExercise
2025-11-12 · Kiniksa Pharmaceuticals International, plc
$615.5K
KNSASell
2025-10-28 · Kiniksa Pharmaceuticals International, plc
$4.1K
KNSAExercise
2025-10-28 · Kiniksa Pharmaceuticals International, plc
$3.1K
KNSATax
2025-09-02 · Kiniksa Pharmaceuticals International, plc
$30.9K
KNSAExercise
2025-09-02 · Kiniksa Pharmaceuticals International, plc
1,861
KNSATax
2025-09-01 · Kiniksa Pharmaceuticals International, plc
$97.8K
KNSAExercise
2025-09-01 · Kiniksa Pharmaceuticals International, plc
2,694
KNSAExercise
2025-09-01 · Kiniksa Pharmaceuticals International, plc
1,750
KNSAExercise
2025-09-01 · Kiniksa Pharmaceuticals International, plc
1,592
KNSASell
2025-08-04 · Kiniksa Pharmaceuticals International, plc
$621.3K
KNSAExercise
2025-08-04 · Kiniksa Pharmaceuticals International, plc
$432.4K
KNSASell
2025-06-03 · Kiniksa Pharmaceuticals International, plc
$527.0K
KNSAExercise
2025-06-03 · Kiniksa Pharmaceuticals International, plc
$329.4K

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.